Literature DB >> 27096392

Synchronous giant hepatic adenoma in siblings-A case report and brief literature review.

Chengsheng Zhang1,2, Xuetao Shi1, Lei Zhao1.   

Abstract

A 47-year-old woman was referred to our department for a hepatic mass. She denied history of hepatitis or alcohol consumption and regular oral contraceptive use, except for the emergency contraceptive pill taken once a decade ago. Hepatitis B surface antigen and anti-hepatitis C antibody were negative, α-fetoprotein was within normal limit. CT scan revealed an enormous mass measuring 26.0×16 5×13 0 cm that almost totally replaced the right hepatic lobe. The neoplasm was completely resected and pathologically diagnosed as hepatic adenoma. Literature review indicates this is the largest hepatic adenoma reported so far. At the same time, clinical examination also revealed a hepatic mass in the patient's 42-year-old brother, which was pathologically confirmed as hepatic adenoma, too. He denied history of anabolic steroid use. Immunohistochemical analysis revealed the subtypes of both tumors as the inflammatory hepatic adenoma. Literature review indicates this is the first report of synchronous hepatic adenomas in siblings.

Entities:  

Keywords:  Environment and public health; hepatocellular adenoma; steroid

Mesh:

Year:  2016        PMID: 27096392      PMCID: PMC4970524          DOI: 10.1080/15384047.2016.1177682

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  19 in total

1.  Hepatic adenoma following short period of oral contraceptive use.

Authors:  C C Naduka
Journal:  J Am Board Fam Pract       Date:  1999 Jul-Aug

2.  High estrogen concentrations in receiving river discharge from a concentrated livestock feedlot.

Authors:  Te-San Chen; Ting-Chien Chen; Kuei-Jyum C Yeh; How-Ran Chao; Ean-Tun Liaw; Chi-Ying Hsieh; Kuan-Chung Chen; Lien-Te Hsieh; Yi-Lung Yeh
Journal:  Sci Total Environ       Date:  2010-05-07       Impact factor: 7.963

3.  Liver pathology associated with the use of anabolic-androgenic steroids.

Authors:  K L Søe; M Søe; C Gluud
Journal:  Liver       Date:  1992-04

Review 4.  Malignant transformation of liver adenoma: an analysis of the literature.

Authors:  Olivier Farges; Safi Dokmak
Journal:  Dig Surg       Date:  2010-04-01       Impact factor: 2.588

5.  Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit.

Authors:  T Leese; O Farges; H Bismuth
Journal:  Ann Surg       Date:  1988-11       Impact factor: 12.969

Review 6.  Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature.

Authors:  L Socas; M Zumbado; O Pérez-Luzardo; A Ramos; C Pérez; J R Hernández; L D Boada
Journal:  Br J Sports Med       Date:  2005-05       Impact factor: 13.800

7.  Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families.

Authors:  Yves Reznik; Thong Dao; Regis Coutant; Laurence Chiche; Emmanuelle Jeannot; Severine Clauin; Pierre Rousselot; Monique Fabre; Frederic Oberti; Armelle Fatome; Jessica Zucman-Rossi; Christine Bellanne-Chantelot
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

8.  Anabolic steroid abuse causing recurrent hepatic adenomas and hemorrhage.

Authors:  Nicole M Martin; Barham K Abu Dayyeh; Raymond T Chung
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

9.  Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy.

Authors:  Jeremiah L Deneve; Timothy M Pawlik; Steve Cunningham; Bryan Clary; Srinevas Reddy; Charles R Scoggins; Robert C G Martin; Michael D'Angelica; Charles A Staley; Michael A Choti; William R Jarnagin; Richard D Schulick; David A Kooby
Journal:  Ann Surg Oncol       Date:  2009-01-08       Impact factor: 5.344

10.  Hepatic adenoma. Timing for surgery.

Authors:  E Chaib; J Gama-Rodrigues; Marcelo A F Ribeiro; P Herman; William A Saad
Journal:  Hepatogastroenterology       Date:  2007 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.